New malaria treatments essential as drug resistance grows
Research being conducted by Burnet scientists is helping to develop new drugs to combat malaria, which is becoming resistant to existing drugs.
Mar 10, 2022
1
33
Research being conducted by Burnet scientists is helping to develop new drugs to combat malaria, which is becoming resistant to existing drugs.
Mar 10, 2022
1
33
A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.
Apr 9, 2013
0
0
(HealthDay)—Tony Head was depressed and fearing death from stage 4 prostate cancer when, as part of a supervised scientific trial, he took a large dose of the psychedelic agent in "magic mushrooms," psilocybin.
Dec 6, 2021
1
91
A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.
Nov 20, 2020
0
3
A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial.
May 3, 2020
0
55
An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.
Aug 27, 2020
0
23
(Medical Xpress)—A team of researchers from several institutions in the U.K. and one in the U.S. has developed a faster and cheaper way to figure out which drugs on the market might be useful for treating other ailments. ...
A prostate cancer drug won't be offered on the NHS any earlier in the treatment plans of patients living with the disease in England, after it failed to pass a cost-effectiveness review.
Apr 8, 2019
0
2
Researchers from Protein Production UK, a collaborative project led by The Rosalind Franklin Institute, have isolated nanobodies—a type of antibody used in research, which bind to the 'spike' protein of the SARS-CoV-2 virus.
Apr 18, 2020
0
163
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway ...
Apr 20, 2020
0
1024